IP Library Granted Patent US 9,462,969
Granted Patent B2
US 9,462,969 · App. 13/265,290 · Granted Oct 11, 2016

Microneedle

Inventors: Feng Gao (Espoo, FI); Jyrki Kiihamäki (Espoo, FI); Ari Hokkanen (Espoo, FI); Päivi Heimala (Espoo, FI)
Assignee: Teknologian tutkimuskeskus VTT Oy
A61B5/1411A61B5/14514A61B5/150022A61B5/15142A61B5/150282A61B5/150419A61B5/150435A61B5/150511A61M37/0015A61B2562/0295A61M2037/003A61M2037/0053A61M2037/0061
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,462,969
App. No.
13/265,290
Granted
Oct 11, 2016
Kind
B2
Abstract

The application relates to microfluidic needles and their manufacturing methods. The microfluidic needle comprises an interface portion containing at least one fluid communication channel, an elongated needle portion ( 40 ) projecting away from the interface portion ( 44 ), the needle portion having a tip and sidewalls connecting the tip to the interface portion, and at least two microfluidic channels ( 43 A-B) within the needle portion in fluidic connection with the at least one communication channel, the microfluidic channels being at least partly oriented parallel to the elongated needle portion. According to the application, the microfluidic channels exit the needle portion at the sidewalls of the needle portion. The needle may be fabricated by ALD-assisted silicon micromachining. The needle can be used for injection and/or sampling fluids to/from tissue or individual cells.

Claims (31)

1. A microfluidic needle comprising:

an interface portion containing at least two fluid communication channels;

an elongated needle portion projecting away from the interface portion, the needle portion having a tapering tip portion, connected to an exterior sidewall connecting the tip portion to the interface portion, the exterior sidewall extending perpendicularly from the interface portion; and

at least two microfluidic channels, being in fluidic and individual connection with one of the at least two communication channels, and extending from the interface portion toward the tip within the needle portion, wherein

the at least two microfluidic channels turn perpendicularly within the needle portion so that each of the at least two microfluidic channels exits only at the sidewall extending perpendicularly from the interface portion on different sides of the top half of the needle portion under the tip so as to prevent clogging.

2. The microfluidic needle according to claim 1 , wherein the interface portion comprises at least two fluid communication channels which can be individually fed with fluid.

3. The microfluidic needle according to claim 1 , wherein the at least one fluid communication channel of the interface portion is in fluidic connection with one or more of the at least two microfluidic channels of the needle portion.

4. The microfluidic needle according to claim 1 , wherein the interface portion is mountable to a surface such that one of the at least two fluid communication channels can be fed with fluid perpendicularly to the direction of the needle portion.

5. The microfluidic needle according to claim 1 , wherein it is manufactured from silicon.

6. The microfluidic needle according to claim 1 , wherein the microfluidic channels exit the needle portion at different sides of the needle portion in symmetric configuration.

7. The microfluidic needle according to claim 1 , wherein there are two, three, four, five or six microfluidic channels in the needle portion.

8. The microfluidic needle according to claim 1 , wherein the needle portion is generally circular in cross-section.

9. The microfluidic needle according to claim 1 , wherein the height of the needle portion is 200-400 μm, and the width of the microfluidic channels in the radial direction of the needle portion is 2-80 μm.

10. The microfluidic needle according to claim 9 , wherein the width of the microfluidic channels in the radial direction of the needle portion is 5-60 μm.

11. The microfluidic needle according to claim 1 ,

wherein a diameter of the needle portion is 1-250 μm,

a height of the needle portion is 5-600 μm, and

a width of the microfluidic channels in the radial direction of the needle portion is 2-80 μm.

12. The microfluidic needle according to claim 1 , wherein the at least two microfluidic channels are separated from each other.

13. The microfluidic needle according to claim 1 , wherein the elongated needle portion has a circular cross section of constant diameter, apart from the tapering tip portion.

14. A microneedle array comprising a plurality of microfluidic needles having:

an interface portion containing at least two fluid communication channels;

an elongated needle portion projecting away from the interface portion, the needle portion having a tapering tip portion, connected to an exterior sidewall connecting the tip portion to the interface portion, the exterior sidewall extending perpendicularly from the interface portion; and

at least two microfluidic channels, being in fluidic and individual connection with one of the at least two communication channels, and extending from the interface portion toward the tip within the needle portion, wherein

the at least two microfluidic channels turn perpendicularly within the needle portion so that each of the at least two microfluidic channels exits only at the sidewall extending perpendicularly from the interface portion on different sides of the top half of the needle portion under the tip so as to prevent clogging and

wherein the plurality of needles have a common interface portion.

15. The microneedle array according to claim 14 , wherein at least one of the at least two communication channels of the common interface portion is in fluidic connection with the microfluidic channels of two or more of the microfluidic needles.

16. A method of using a microneedle, comprising:

providing a microneedle having an interface portion containing at least two fluid communication channels; an elongated needle portion projecting away from the interface portion, the needle portion having a tapering tip portion, connected to an exterior sidewall connecting the tip to the interface portion, the exterior sidewall extending perpendicularly from the interface portion; and at least two microfluidic channels, being in fluidic and individual connection with one of the at least two communication channels, and extending from the interface portion toward the tip within the needle portion, wherein the at least two microfluidic channels turn perpendicularly within the needle portion so that each of the at least two microfluidic channels exits only at the sidewall extending perpendicularly from the interface portion on different sides of the top half of the needle portion under the tip so as to prevent clogging; and

pipetting fluids at least one of: to an individual cell through the microneedle and from an individual cell through the microneedle.

17. The method according to claim 16 , wherein said pipetting is non-therapeutic or takes place ex vivo or in vitro.

Assignments (2)
CHANGE OF NAME Recorded Aug 30, 2016
From: TEKNOLOGIAN TUTKIMUSKESKUS VTT
To: TEKNOLOGIAN TUTKIMUSKESKUS VTT OY
Reel/Frame 039863/0596 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2011
From: GAO, FENG; KIIHAMAKI, JYRKI; HOKKANEN, ARI; HEIMALA, PAIVI
To: TEKNOLOGIAN TUTKIMUSKESKUS VTT
Reel/Frame 027161/0870 →
Priority Claims (1)
FI 20095433 · Apr 20, 2009 · national
Continuity (1)
Related Publication 20120058506A1 · Mar 8, 2012